Autoimmune and inflammatory diseases represent complex conditions wherein the body's immune system mistakenly targets its own tissues, resulting in inflammation and subsequent tissue damage. Typically, the immune system's role involves identifying and neutralizing foreign invaders, such as bacteria and viruses, while preserving the body's own cells. However, in autoimmune disorders, this intricate self-recognition mechanism malfunctions, leading to the immune system erroneously attacking healthy cells, tissues, and organs. This dysregulation manifests in over 80 recognized autoimmune diseases, each characterized by distinct symptoms and affecting various parts of the body. Conditions like rheumatoid arthritis, lupus, multiple sclerosis, type 1 diabetes, and inflammatory bowel diseases such as Crohn's disease and ulcerative colitis are prime examples. Conversely, inflammatory diseases stem from the body's response to injury, infection, or irritation. Inflammation itself is a vital process for healing, facilitating the removal of harmful stimuli and initiating tissue repair. However, chronic inflammation arises when the immune system remains continually activated, leading to ongoing tissue damage and contributing to ailments like asthma, chronic obstructive pulmonary disease (COPD), and cardiovascular diseases. Both autoimmune and inflammatory diseases exert profound impacts on an individual's quality of life, often necessitating long-term management strategies and treatments to control symptoms and avert complications. Treatment modalities typically encompass medications designed to suppress the immune response, mitigate inflammation, and manage symptoms. Additionally, lifestyle adjustments, including dietary modifications and regular exercise, often play integral roles in managing these conditions effectively.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States